These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9540002)
41. Cibenzoline in the prevention of recurrence of supraventricular arrhythmias. el Allaf D; Schifflers E; Kormoss N Acta Cardiol; 1995; 50(1):53-64. PubMed ID: 7771175 [TBL] [Abstract][Full Text] [Related]
42. [Hypoglycemia caused by cibenzoline. Apropos of a new case]. Noury JF; Delvaux JC Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):7-8. PubMed ID: 2648968 [TBL] [Abstract][Full Text] [Related]
43. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus]. Lazebnik LB; Malichenko SB; Serebrov AN Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279 [No Abstract] [Full Text] [Related]
44. [Cardiogenic shock and major intraventricular block in treatment with cibenzoline]. Aymard Dufour MF; Spriet Pourra C Therapie; 1988 May; 43(3):243-4. PubMed ID: 3420576 [No Abstract] [Full Text] [Related]
46. [Drug information: agents for the treatment of arrhythmia. Therapeutic main group: Anti-arrhythmia agents. 9]. Lumholtz IB Sygeplejersken; 1980 Oct; 80(40):21. PubMed ID: 6905430 [No Abstract] [Full Text] [Related]
47. [Activity and tolerance of a new anti-arrhythmia drug, Cibenzoline (Cipralan), administered orally)]. Herpin D; Gaudeau B; Amiel A; Bauple JL; Boutaud P; Demange J Acta Cardiol; 1981; 36(2):131-48. PubMed ID: 6170199 [TBL] [Abstract][Full Text] [Related]
48. [News on side effects. 59 reports on losartan. Even cough is reported]. Lakartidningen; 1996 Oct; 93(41):3601. PubMed ID: 8965520 [No Abstract] [Full Text] [Related]
49. Ataxia caused by amiodarone in older people. Hindle JV; Ibrahim A; Ramaraj R Age Ageing; 2008 May; 37(3):347-8. PubMed ID: 18385185 [TBL] [Abstract][Full Text] [Related]
50. Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration. Corey AE; Agnew JR; Valentine SN; Parekh NJ; Powell JH; Thompson GA Br J Clin Pharmacol; 2002 Nov; 54(5):449-52. PubMed ID: 12445022 [TBL] [Abstract][Full Text] [Related]
57. Long-term impact of therapeutic drug monitoring on the risk of hypoglycemia in HOCM patients on cibenzoline therapy . Mukai Y; Wada K; Fujimoto M; Hosomi K; Kuwahara T; Takada M Int J Clin Pharmacol Ther; 2016 Oct; 54(10):795-803. PubMed ID: 27443663 [TBL] [Abstract][Full Text] [Related]
58. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial. Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283 [TBL] [Abstract][Full Text] [Related]
59. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia]. Babuty D; Cosnay P; Rouesnel P; Bine-Scheck F; Arnaud R; Fauchier JP Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):225-34. PubMed ID: 1642441 [TBL] [Abstract][Full Text] [Related]
60. Increased mortality in patients with diabetes associated with olmesartan for the prevention/delay of microalbuminuria onset: a matter of concern? Consuegra-Sánchez L; Sanchis J; Núñez J; Cascón JD; Villegas M; Picó F Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):378-80. PubMed ID: 21840109 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]